Informatics applied to pharmacovigilance: Future perspectives
Michele Menniti1, Annamaria Menniti1, Marinella Patanè1, Stefania Esposito1, Chiara Giofrè1, Rossana Aiello1, Emilio Russo1★★ Corresponding author
- 1Department of Science of Health, School of Medicine, University of Catanzaro and Pharmacovigilance Centre, Calabria Region, University Hospital Mater Domini, Catanzaro, Italy.
CORRESPONDENCE
Emilio Russo
Department of Science of Health, School of Medicine, University of Catanzaro and Pharmacovigilance Centre, Calabria Region, University Hospital Mater Domini, Catanzaro, Italy.
Volume 4, Issue 4S · pp. S43–S44 · PUBLISHED 2013 · DOI: 10.4103/0976-500X.120950
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Spontaneous adverse drugs reaction (ADRs) reporting represents a precious resource for control and information about the drug’s safety and pharmacovigilance. The current reporting system is mainly based on handwritten forms and later manually loaded into a national electronic database by few local pharmacovigilance centers. This reporting system is complicated for both reporters and pharmacovigilance centers which often avoid reporting ADRs for several reasons such as the lack of data on the report. The reporting system might be implemented by improving online platform for ADRs upload; this could allow inspecting all ADRs loaded. Currently, the database is only accessible by the Italian Medicine Agency (AIFA) and local pharmacovigilance centers; neither reporters nor other healthcare professionals can access the database. Finally, it would be right to implement pharmacovigilance centers with specific professional figures qualified in the pharmacovigilance to support both citizens and reporters on various aspects of ADRs reporting.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Menniti, M., Menniti, A., Patanè, M., Esposito, S., Giofrè, C., Aiello, R., & Russo, E. (2013). Informatics applied to pharmacovigilance: Future perspectives. Journal of Pharmacology and Pharmacotherapeutics, 4(4S), S43–S44. https://doi.org/10.4103/0976-500X.120950
